FDA Approves Adult Use Of Glaxo Vaccine Boostrix

By: Associated Press Email
By: Associated Press Email

Stay up-to-date with KAKE News:

U.S. regulators have approved the vaccine Boostrix for use in adults. That word from its British-based maker, GlaxoSmithKline.

Boostrix offers protection against tetanus, diphtheria and whooping cough. It was previously approved as a booster vaccine for ages 10 to 18. The Food and Drug Administration approved its use in patients ages 19 to 64.

Whooping cough can linger for weeks in older patients, who usually recover from it. But they can spread it to not-yet-vaccinated infants who can die from the bacterial infection, also called pertussis.

Comments are posted from viewers like you and do not always reflect the views of this station.
powered by Disqus
KAKE TV 1500 N. West Street Wichita, KS 67203-1323 (316) 943-4221
Gray Television, Inc. - Copyright © 2002-2014 - Designed by Gray Digital Media - Powered by Clickability 35797884 - kake.com/a?a=35797884